Literature DB >> 9706551

Impact of viral hemorrhagic disease on a wild population of European rabbits in France.

S Marchandeau1, J Chantal, Y Portejoie, S Barraud, Y Chaval.   

Abstract

An outbreak of rabbit viral hemorrhagic disease (RVHD) and of myxomatosis occurred in a free-living population of rabbits (Oryctolagus cuniculus) near Paris (France) in 1995. Annual mortality rates were 88% in adults and 99% in juveniles. There was no difference in mortality rates between males and females. Since most adults were protected with myxoma antibodies after May, they probably died of RVHD. Mortality lasted throughout the year despite high proportions of rabbits having developed myxomatosis and RVHD antibodies, which suggests that the combination of the two diseases and the immunosuppressive characteristics of myxoma virus could be responsible for the mortality caused by RVHD. The proportion of juveniles with RVHD antibodies increased with their weight. Seroconversion against RVHD occurred in spring and autumn.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706551     DOI: 10.7589/0090-3558-34.3.429

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  6 in total

1.  Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.

Authors:  J Bárcena; M Morales; B Vázquez; J A Boga; F Parra; J Lucientes; A Pagès-Manté; J M Sánchez-Vizcaíno; R Blasco; J M Torres
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  An overview of the lagomorph immune system and its genetic diversity.

Authors:  Ana Pinheiro; Fabiana Neves; Ana Lemos de Matos; Joana Abrantes; Wessel van der Loo; Rose Mage; Pedro José Esteves
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

3.  Emergence of new virulent rabbit hemorrhagic disease virus strains in Saudi Arabia.

Authors:  Mahmoud M Ismail; Mahmoud H A Mohamed; Ibrahim M El-Sabagh; Mohamed A Al-Hammadi
Journal:  Trop Anim Health Prod       Date:  2016-12-02       Impact factor: 1.559

4.  Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.

Authors:  J M Torres; M A Ramírez; M Morales; J Bárcena; B Vázquez; E Espuña; A Pagès-Manté; J M Sánchez-Vizcaíno
Journal:  Vaccine       Date:  2000-09-15       Impact factor: 3.641

5.  Comparative quantitative monitoring of rabbit haemorrhagic disease viruses in rabbit kittens.

Authors:  Markus Matthaei; Peter J Kerr; Andrew J Read; Paul Hick; Stephanie Haboury; John D Wright; Tanja Strive
Journal:  Virol J       Date:  2014-06-09       Impact factor: 4.099

Review 6.  Emergence of Pathogenicity in Lagoviruses: Evolution from Pre-existing Nonpathogenic Strains or through a Species Jump?

Authors:  Pedro José Esteves; Joana Abrantes; Stéphane Bertagnoli; Patrizia Cavadini; Dolores Gavier-Widén; Jean-Sébastien Guitton; Antonio Lavazza; Evelyne Lemaitre; Jérôme Letty; Ana Margarida Lopes; Aleksija S Neimanis; Nathalie Ruvoën-Clouet; Jacques Le Pendu; Stéphane Marchandeau; Ghislaine Le Gall-Reculé
Journal:  PLoS Pathog       Date:  2015-11-05       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.